Abstract

Immune checkpoint inhibitors (ICIs) are associated with a unique spectrum of side effects known as immune related adverse events (irAE). It has also been hypothesized that occurrence of irAE is associated with better survival. There is paucity of literature of the safety profile of ICIs in India and its association with survival.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.